A feasibility study on predicting disease progression in high-grade gliomas using magnetic resonance imaging habitat radiomics based on response assessment in neuro-oncology (RANO) criteria
Open Access
- 6 January 2026
- journal article
- Published by SAGE Publications in Digital Health
- Vol. 12
Abstract
Objective: Investigating progression risk insights of high-grade gliomas through habitat radiomics analysis. Methods: A cohort of 89 patients with high-grade gliomas was enrolled, with 63 patients in the train cohort and 26 patients in the test cohort. The methodology involved delineating the region of interest (ROI) within the tumor area on magnetic resonance imaging images, followed by multisequence registration. The ROI was further divided into subregions using K -means clustering. Radiomics features were extracted from the subregions, and feature selection was performed using least absolute shrinkage and selection operator regression. Four separate models were created: radiomics model, clinical model, habitat model, and combined model that merged the habitat signature with clinical factors. The accuracy of the models was evaluated using concordance index (C-index) and receiver operating characteristic analysis. Results: The ROI was divided into three subregions, from which 36 features were extracted and selected. The habitat model, radiomics model, clinical model, and combined model were constructed by combining the extracted features with clinical data. The habitat model showed excellent predictive performance with the C-index values of 0.879 in the train cohort and 0.781 in the test cohort. Using this model, patients were classified into high-risk and low-risk groups, resulting in significantly different median progression-free survival (mPFS) times of 7 and 31 months, respectively ( P < 0.001). Stratifying the patient cohort based on isocitrate dehydrogenase status also revealed distinct mPFS outcomes for high-risk and low-risk patients. Conclusion: The habitat model demonstrated outstanding predictive performance for forecasting the progression risk of patients with high-grade gliomas.Keywords
This publication has 29 references indexed in Scilit:
- Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary StudyFrontiers in Neuroscience, 2022
- Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancerNature Cancer, 2022
- Spatial heterogeneity of edema region uncovers survival-relevant habitat of GlioblastomaEuropean Journal of Radiology, 2022
- Low conductivity on electrical properties tomography demonstrates unique tumor habitats indicating progression in glioblastomaEuropean Radiology, 2021
- Spatiotemporal Heterogeneity in Multiparametric Physiologic MRI Is Associated with Patient Outcomes in IDH-Wildtype GlioblastomaClinical Cancer Research, 2021
- Identification of Early Response to Anti-Angiogenic Therapy in Recurrent Glioblastoma: Amide Proton Transfer–weighted and Perfusion-weighted MRI compared with Diffusion-weighted MRIRadiology, 2020
- Vascular habitat analysis based on dynamic susceptibility contrast perfusion MRI predicts IDH mutation status and prognosis in high-grade gliomasEuropean Radiology, 2020
- Sensitivity of radiomic features to inter-observer variability and image pre-processing in Apparent Diffusion Coefficient (ADC) maps of cervix cancer patientsRadiotherapy and Oncology, 2020
- Associating spatial diversity features of radiologically defined tumor habitats with epidermal growth factor receptor driver status and 12-month survival in glioblastoma: methods and preliminary investigationJournal of Medical Imaging, 2015
- Gliomas: Predicting Time to Progression or Survival with Cerebral Blood Volume Measurements at Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR ImagingRadiology, 2008